ESR1 and breast carcinoma: Therefore, to elucidate the diagnostic value of serum AnxA2 in different breast cancer subtypes, ROC curve analysis based on serum AnxA2 levels of ER+, HER2+ and TNBC breast cancer patients compared to normal healthy patients was evaluated (Figure 3B).